Please try another search
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company’s lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Robert Terkeltaub | - | - | Member of Scientific Advisory Board |
Douglas A. Treco | 66 | 2020 | CEO & Chairman |
Axel Bolte | 52 | 2015 | Co-Founder, Senior Advisor & Director |
Frank Rutsch | - | - | Member of Clinical Advisory Board |
Edward Y. Skolnik | - | - | Member of Scientific Advisory Board |
Thomas O. Carpenter | - | - | Member of Clinical Advisory Board |
Yves Sabbagh | - | 2020 | Chairman of Scientific Advisory Board & Senior VP |
W. Charles O’Neill | - | 2021 | Member of Scientific Advisory Board |
Jouni Uitto | - | 2021 | Member of Scientific Advisory Board |
Paul B. Yu | - | 2021 | Member of Scientific Advisory Board |
Reinaldo M. Diaz | 70 | 2017 | Lead independent director |
Joseph P. Schlessinger | 79 | 2015 | Member of Scientific Advisory Board |
Michael A. Levine | - | - | Chairperson of Clinical Advisory Board |
Lynne Marie Sullivan | 58 | 2020 | Independent Director |
Sarah Bhagat | 37 | 2019 | Independent Director |
Robert L. Hopfner | 51 | 2018 | Independent Director |
Edward T. Mathers | 64 | 2017 | Independent Director |
Martin William Edwards | 68 | 2017 | Independent Director |
Demetrios Braddock | - | - | Co-Founder, Scientific Founder, Member of Scientific Advisory Board & Board Observer |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review